Biogen Halts Studies of Closely Watched Alzheimer’s Drug, a Blow to Hopes for New Treatment
Trial failure raises doubts about amyloid as a target for drug development
Stories by Adam Feuerstein
FDA Approves First New Drug Developed for Women with Postpartum Depression
The new drug, Zulresso, can work in days, not the weeks it takes for current treatments
Poliovirus Therapy Shows Early Promise for Treating Aggressive Brain Cancer, but Questions Linger
Survival was better than expected with this genetically modified pathogen
The Most Expensive U.S. Medicine Now Has an Official Sticker Price
This gene therapy for vision loss will initially cost $850,000
FDA Approves First Gene Therapy Targeting Rare Form of Inherited Blindness
The historic treatment’s costs could top $1 million
Novel Gene Therapy for Leukemia Clears FDA Panel
The experimental treatment will now face review by the agency
FDA Approves First Sickle Cell Drug in 20 Years
Approximately 100,000 people in the U.S. have the disorder
